Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06754657

CORA-Q15: Continuous vs. Single-injection Interscalene Block on QoR-15 in Outpatient Rotator Cuff Surgery

Comparison of Continuous vs. Single-injection Interscalene Block on QoR-15 in Outpatient Rotator Cuff Surgery: A Randomized Study Assessing Non-inferiority and Superiority (CORA-Q15)

Status
Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
Pontificia Universidad Catolica de Chile · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study will be to compare the efficacy of single-injection interscalene block versus continuous interscalene block on the quality of recovery in patients undergoing outpatient arthroscopic rotator cuff repair surgery. The participants will: * Be randomized to receive either a single-injection interscalene block or continuous infusion via an elastomeric pump. * Be monitored via telephone by the research team to complete the QoR-15 survey, assess pain levels, the need for tramadol use, and any complications. * Have follow-up by the Acute Pain Unit during the first 3 days.

Detailed description

After obtaining approval from the institutional CEC-CCSS and prospective registration of the study at clinicaltrials.org, the investigators will recruit patients who meet the inclusion criteria and provide written consent. Following surgery and placement of the interscalene block with a catheter, in the recovery unit, participants will be assigned to one of two groups according to a random number table, in a 1:1 ratio using block randomization (block sizes of 4, 6, and 8) through sealed envelopes.

Conditions

Interventions

TypeNameDescription
PROCEDUREContinuous perineural infusioninfusion rate 4 ml/h, with 5 ml boluses (30-minute lockout). The PCA button disabled
PROCEDURESingle injectioninfusion rate 0 ml/h, with 5 ml boluses (30-minute lockout). The PCA button will be enabled for rescue bolus administration

Timeline

Start date
2025-05-26
Primary completion
2026-12-31
Completion
2027-03-31
First posted
2025-01-01
Last updated
2025-05-30

Locations

1 site across 1 country: Chile

Source: ClinicalTrials.gov record NCT06754657. Inclusion in this directory is not an endorsement.